2017-2021 France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents French test volume and sale forecasts for HIV-1/2/Combo, HIVAg, NAT, Western Blot, and other confirmatory assays performed in the following market segments:
- Hospitals
- Commercial/Private Labs
- Blood Banks
Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV1/2/Combo Test Volume and Sales Forecast by Market Segment
France: HIV Ag Test Volume and Sales Forecast by Market
Segment
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
France: HIV or HIV1/2/Combo Test Volume and Sales Forecast by Market Segment
France: HIV Ag Test Volume and Sales Forecast by Market
Segment
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
More Publications
2017-2021 Spain HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,070.00
January 2017
250 pages
2017-2021 UK HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,070.00
January 2017
251 pages
2017-2021 US HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,070.00
January 2017
250 pages